Drugs / Live Combined Bifidobacterium and Lactobacillus Tablets
Live Combined Bifidobacterium and Lactobacillus Tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05406882 | Apr 2022 → Apr 2024 | radiation proctitis | West China Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live Combined Bifidobacterium and Lactobacillus Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05406882 ↗ |
| Modality | Other / unclassified | “Live Combined Bifidobacterium and Lactobacillus Tablets：probiotics.” NCT05406882 ↗ |
| Route | Oral | “the experimental drug orally” NCT05406882 ↗ |